Resources
For the latest in nextgen biomed, sign up for our monthly newsletter to be among the first to receive exclusive insights, in-depth market analyses, and expert articles directly to your inbox
A concise report featuring insights from the prominent thought leaders of Biologics 2024
Exploring Innovative Approaches Throughout the CGT Development Journey
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Cell UK
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Manufacturing & Bioprocessing
In Conversation With...Ruth Faram, HigherSteaks
Dr. Faram is co-founder and Chief Scientific Officer at HigherSteaks, where she leads the company strategy and research focus for the Stem Cell, Bioprocess, Differentiation and Biomaterial teams.
Manufacturing & Bioprocessing
Novel Technologies Advancing Downstream Bioprocessing
Tuhina Bhattacharya, Associate Director of CMC Biologics at Corbus Pharmaceuticals, leads a Discussion Group on the future of downstream bioprocessing technologies.
Antibody & Protein Engineering
Is Your WASH Causing Inflammation? Protein Complex Linked to Inflammatory Conditions
Research published by the Scripps Research Institute reveals the WASH protein complex as a crucial factor in neutrophil-triggered inflammation.
Why We Develop Autoimmunity: Hyperstimulation of Genetically Prone Subjects
Professor Yehuda Shoenfeld explains his findings in establishing links between genetic predisposition and hyperstimulation of the immune system and how this may help us better understand the development of autoimmunity.
Advanced Vaccine Platforms & Technologies
Wieslaw Swietnicki, Head of Biosynthesis and Bioengineering Group at the Institute of Industrial Organic Chemistry, leads a discussion on the current outlook for advanced vaccine platforms, technologies, and development.
Drug Discovery & Development
The Challenges Facing Antibody-Drug Conjugates for Immuno-Oncology
The targeted cancer therapy has made recent clinical and market breakthroughs, but what are the next hurdles for ADCs?
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things discovery